189eP No survival benefit from interval debulking surgery in elderly patients with advanced ovarian cancer: Evidence from real-world practice
Year: 2026
Type: article
Study design: Observational Study
Abstract: Elderly patients with ovarian cancer are underrepresented in clinical trials and often receive less intensive treatment. The role of cytoreductive surgery, particularly interval debulking surgery (IDS), in this population remains unclear. We aimed to evaluate real-world outcomes and the impact of surgical strategies in elderly patients with epithelial ovarian cancer.
Source: ESMO Open
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7167040355
FWCI:
Cites:
Cited by:
Related to:
